Endovirus MNP EV71 type vaccine
Painless MNP that contains vaccine for EV71 type virus

WCC is working together with the National Health Research Institute (NHRI) to develop vaccine MNP for EV 71 type. NHRI is the only institute that develops advanced B5 type vaccine for EV71 in Asia, MNP that contains B5 for EV71 type potentially has several advantages as follows:

  1. The amount of vaccine can be substantially reduced to less than 20 %.
  2. Painless application is highly acceptable.
  3. No need to go to hospitals.
  4. MNP is in solid form, no need for low-temperature storage, transportation is much cheaper (cold chain not required.)